Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2013
PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomasAnat Erdreich-Epstein, Nathan Robison, Xiuhai Ren, et al.The Journal of Clinical Investigation|February 16, 2008
Proteomic identification of FHL1 as the protein mutated in human reducing body myopathyJoachim Schessl, Yaqun Zou, Meagan J McGrath, et al.Cancer Cell|August 16, 2020
Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine GliomasChan Chung, Stefan R Sweha, Drew Pratt, et al.The Journal of Molecular Diagnostics : JMD|August 24, 2018
OncoKids: A Comprehensive Next-Generation Sequencing Panel for Pediatric MalignanciesMatthew C Hiemenz, Dejerianne G Ostrow, Tracy M Busse, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2020
Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333Alyssa T Reddy, Douglas R Strother, Alexander R Judkins, et al.Science Translational Medicine|November 25, 2016
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomasJill Bayliss, Piali Mukherjee, Chao Lu, et al.Ebiomedicine|April 29, 2021
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case seriesThao T Truong, Alex Ryutov, Utsav Pandey, et al.Brain Pathology (Zurich, Switzerland)|February 27, 2013
PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastomaJoanna J Phillips, Derick Aranda, David W Ellison, et al.Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunityThao T Truong, Alex Ryutov, Utsav Pandey, et al.Nature Communications|February 6, 2019
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancerYibo Xue, Brian Meehan, Zheng Fu, et al.Pageof 9